Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Study of Allisartan Isoproxil in Healthy Chinese Participants
NCT07174830Phase 4Recruiting
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Start
- Sep 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of allisartan isoproxil in essential hypertension, sponsored by Shenzhen Salubris Pharmaceuticals Co., Ltd.. Started Sep 2025; status: recruiting.
02
Drugs
allisartan isoproxil
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT07174830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07174830.